Airain Ltd’s Aegerion Pharmaceuticals AEGR Stock Holding History

Airain Ltd’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-37,387	Closed	-$1.25M	–	1041
2014 Q3	$1.25M	Buy	+37,387	New	+$1.16M	0.08%	282

Other funds holding AEGR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Airain Ltd's AEGR Position: Q4 2014 in Review

Airain Ltd sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 37,387 shares — an estimated $1.25M sold.

Airain Ltd first reported a position in AEGR in Q3 2014 and held it in 1 quarter. The position peaked at $1.25M in Q3 2014. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

Airain Ltd reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Airain Ltd sold 37,387 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $1.25M.
Airain Ltd first reported a position in Aegerion Pharmaceuticals in Q3 2014 and held it in 1 quarter.
Airain Ltd's Aegerion Pharmaceuticals position peaked at $1.25M in Q3 2014.
95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Airain Ltd's 13F filing for Q4 2014, filed 12 Feb 2015.